Callan Family Office’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$218K Buy
+4,007
New +$195K ﹤0.01% 1117
2026
Q1
– Sell
-4,897
Closed -$215K – 1151
2025
Q4
$215K Buy
+4,897
New +$203K ﹤0.01% 1040
2025
Q3
– Sell
-4,981
Closed -$220K – 888
2025
Q2
$220K Buy
+4,981
New +$199K 0.01% 871

Other funds holding EXEL

Callan Family Office's EXEL Position: Q2 2026 in Review

Callan Family Office opened a new position in Exelixis (EXEL) in Q2 2026: 4,007 shares worth $218K. The stake represents ﹤0.01% of the portfolio and ranks #1117 among its holdings. This is a return to the name: Callan Family Office previously reported a position in EXEL as recently as Q4 2025.

Callan Family Office first reported a position in EXEL in Q2 2025 and has held it in 3 quarters since. The position peaked at $220K in Q2 2025. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Callan Family Office held 4,007 shares of Exelixis worth $218K as of Q2 2026.
  • Exelixis was a new Callan Family Office position in Q2 2026.
  • Exelixis made up ﹤0.01% of Callan Family Office's portfolio in Q2 2026, its #1117 holding.
  • Callan Family Office first reported a position in Exelixis in Q2 2025 and has held it in 3 quarters since.
  • Callan Family Office's Exelixis position peaked at $220K in Q2 2025.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.